Credit Suisse’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $356K | Sell |
|
|||||
|
2022
Q3 | $1.61M | Buy |
|
|||||
|
2022
Q2 | $573K | Sell |
|
|||||
|
2022
Q1 | $664K | Buy |
|
|||||
|
2021
Q4 | $1.26M | Sell |
|
|||||
|
2021
Q3 | $2.15M | Sell |
|
|||||
|
2021
Q2 | $3.71M | Buy |
|
|||||
|
2021
Q1 | $1.59M | Sell |
|
|||||
|
2020
Q4 | $3.1M | Buy |
|
|||||
|
2020
Q3 | $4.49M | Sell |
|
|||||
|
2020
Q2 | $2.66M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $459K | Buy |
|
|||||
|
2019
Q3 | $161K | Buy |
|
|||||
|
2019
Q2 | $191K | Sell |
|
|||||
|
2019
Q1 | $364K | Buy |
|
|||||
|
2018
Q4 | $160K | Buy |
|
|||||
|
2018
Q3 | $278K | Sell |
|
|||||
|
2018
Q2 | $529K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $48K | Sell |
|
|||||
|
2016
Q4 | $85K | Buy |
|
|||||
|
2016
Q3 | $112K | Sell |
|
|||||
|
2016
Q2 | $94K | Buy |
|
|||||
|
2016
Q1 | $72K | Sell |
|
|||||
|
2015
Q4 | $118K | Sell |
|
|||||
|
2015
Q3 | $114K | Buy |
|
|||||
|
2015
Q2 | $226K | Sell |
|
|||||
|
2015
Q1 | $689K | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $241K | Buy |
|